Long-term Survival Outcomes of Endoscopic Therapy Vs. Surgical Resection in Patients with Cardia Gastrointestinal Stromal Tumor

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2024 Jul 5

PMID 38968220

Authors

Qiong Wu

Jun Jiang

Zhuofan Li

Xin Ling

Zhenguo Qiao

Yimin Ma

Affiliations

Soon will be listed here.

Abstract

The ideal surgical approach for treating cardia gastrointestinal stromal tumor (GIST) is not clearly established. This study aimed to assess the long-term survival results among patients who received endoscopic therapy (ET) or surgical resection (SR) for cardia GIST. Cardia GIST patients from 2000 to 2019 were selected from the surveillance, epidemiology, and end result (SEER) database. Multiple imputation (MI) was applied to handle missing data, and propensity score matching (PSM) was carried out to mitigate selection bias during comparisons. Demographic and clinical characteristics' effects on overall survival (OS) and cancer-specific survival (CSS) were assessed using Kaplan-Meier analyses and multivariate Cox proportional hazard models. A total of 330 patients with cardia GIST were enrolled, including 47 (14.2%) patients with ET and 283 (85.8%) patients with SR. The 5-year OS and CSS rates in the ET and SR groups were comparable [before PSM, (OS) (76.1% vs. 81.2%, P = 0.722), (CSS) (95.0% vs. 89.3%, P = 0.186); after PSM, (OS) (75.4% vs. 85.4%, P = 0.540), (CSS) (94.9% vs. 92.0%, P = 0.099)]. Moreover, there was no significant difference between ET and SR in terms of long-term OS (hazard ratio [HR] 0.735, 95% confidence interval [CI] 0.422-1.282) and CSS (HR 1.560, 95% CI 0.543-4.481). Our study found no significant disparity in long-term survival outcomes between ET and SR in cardia GIST patients, implying that ET could be a valid surgical strategy for treating cardia GIST.

References

Wang S, Shen L . Efficacy of Endoscopic Submucosal Excavation for Gastrointestinal Stromal Tumors in the Cardia. Surg Laparosc Endosc Percutan Tech. 2016; 26(6):493-496. DOI: 10.1097/SLE.0000000000000330. View

Miettinen M, Lasota J, Sobin L . Gastrointestinal stromal tumors of the stomach in children and young adults: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases with long-term follow-up and review of the literature. Am J Surg Pathol. 2005; 29(10):1373-81. DOI: 10.1097/01.pas.0000172190.79552.8b. View

Guller U, Tarantino I, Cerny T, Schmied B, Warschkow R . Population-based SEER trend analysis of overall and cancer-specific survival in 5138 patients with gastrointestinal stromal tumor. BMC Cancer. 2015; 15:557. PMC: 4518595. DOI: 10.1186/s12885-015-1554-9. View

Mantese G . Gastrointestinal stromal tumor: epidemiology, diagnosis, and treatment. Curr Opin Gastroenterol. 2019; 35(6):555-559. DOI: 10.1097/MOG.0000000000000584. View

Khan J, Ullah A, Waheed A, Karki N, Adhikari N, Vemavarapu L . Gastrointestinal Stromal Tumors (GIST): A Population-Based Study Using the SEER Database, including Management and Recent Advances in Targeted Therapy. Cancers (Basel). 2022; 14(15). PMC: 9367571. DOI: 10.3390/cancers14153689. View

Akahoshi K, Oya M, Koga T, Shiratsuchi Y . Current clinical management of gastrointestinal stromal tumor. World J Gastroenterol. 2018; 24(26):2806-2817. PMC: 6048423. DOI: 10.3748/wjg.v24.i26.2806. View

De Lima D, Alberti L . Endoscopic resection of a cardia gastrointestinal stromal tumour (GIST) after echoendoscopy. Acta Gastroenterol Latinoam. 2012; 42(3):230-3. View

Kramer K, Knippschild U, Mayer B, Bogelspacher K, Spatz H, Henne-Bruns D . Impact of age and gender on tumor related prognosis in gastrointestinal stromal tumors (GIST). BMC Cancer. 2015; 15:57. PMC: 4384379. DOI: 10.1186/s12885-015-1054-y. View

Fujimoto Y, Nakanishi Y, Yoshimura K, Shimoda T . Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients. Gastric Cancer. 2003; 6(1):39-48. DOI: 10.1007/s101200300005. View

10.

Yang Z, Feng X, Zhang P, Chen T, Qiu H, Zhou Z . Clinicopathological features and prognosis of 276 cases of primary small (≤ 2 cm) gastric gastrointestinal stromal tumors: a multicenter data review. Surg Endosc. 2018; 33(9):2982-2990. DOI: 10.1007/s00464-018-6564-7. View

11.

Singer S, Rubin B, Lux M, Chen C, Demetri G, Fletcher C . Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors. J Clin Oncol. 2002; 20(18):3898-905. DOI: 10.1200/JCO.2002.03.095. View

12.

Joo M, Park J, Lee Y, Lee B, Kim S, Kim W . Clinical Efficacy and Safety of Endoscopic Treatment of Gastrointestinal Stromal Tumors in the Stomach. Gut Liver. 2023; 17(2):217-225. PMC: 10018311. DOI: 10.5009/gnl210454. View

13.

Tanigawa K, Kanaji S, Sawada R, Harada H, Urakawa N, Goto H . Safety of laparoscopic local resection for gastrointestinal stromal tumors near the esophagogastric junction. Surg Today. 2021; 52(3):395-400. DOI: 10.1007/s00595-021-02345-y. View

14.

Cavnar M, Seier K, Curtin C, Balachandran V, Coit D, Yoon S . Outcome of 1000 Patients With Gastrointestinal Stromal Tumor (GIST) Treated by Surgery in the Pre- and Post-imatinib Eras. Ann Surg. 2019; 273(1):128-138. PMC: 6774913. DOI: 10.1097/SLA.0000000000003277. View

15.

Chernousov A, Vetshev F, Vychuzhanin D, Khorobrykh T, Egorov A, Osminin S . [Laparoscopic and robot-assisted procedures in patients with gastrointestinal stromal tumors (GIST) of stomach]. Khirurgiia (Mosk). 2020; (1):5-13. DOI: 10.17116/hirurgia20200115. View

16.

Eriksson M, Joensuu H . Adjuvant imatinib for GIST: duration likely matters. Ann Oncol. 2021; 32(4):434-436. DOI: 10.1016/j.annonc.2021.01.073. View

17.

Schwameis K, Fochtmann A, Schwameis M, Asari R, Schur S, Kostler W . Surgical treatment of GIST--an institutional experience of a high-volume center. Int J Surg. 2013; 11(9):801-6. DOI: 10.1016/j.ijsu.2013.08.016. View

18.

Florin C, Bogdan F, Cristian L, Maria T, Mihai D, Viorel S . Surgical Treatment of Gastric GIST: Feasibility of Laparoscopic Resection and Postoperative Outcome. J Coll Physicians Surg Pak. 2020; 30(5):519-522. DOI: 10.29271/jcpsp.2020.05.519. View

19.

Du C, Chai N, Linghu E, Li H, Zhai Y, Li L . Clinical outcomes of endoscopic resection for the treatment of gastric gastrointestinal stromal tumors originating from the muscularis propria: a 7-year experience from a large tertiary center in China. Surg Endosc. 2021; 36(2):1544-1553. DOI: 10.1007/s00464-021-08443-9. View

20.

Liu S, Zhou X, Yao Y, Shi K, Yu M, Ji F . Resection of the gastric submucosal tumor (G-SMT) originating from the muscularis propria layer: comparison of efficacy, patients' tolerability, and clinical outcomes between endoscopic full-thickness resection and surgical resection. Surg Endosc. 2020; 34(9):4053-4064. PMC: 7394934. DOI: 10.1007/s00464-019-07311-x. View